Echogenic Versus Non-echogenic Needles for Venous Access

University of Oslo (UIO)

Status: Completed

Conditions: Vascular Access Complication; Anesthesia

Treatments: Device: echogenic needles for intravenous access

Study type: Interventional

Funder types: Other

Identifiers

NCT05045352

REK 85090

Details and patient eligibility

About

Randomized controlled intervention study comparing echogenic needles with non echogenic needles for ultrasound guided venous access in the subclavian vein.

Full description

Patients undergoing certain surgical procedures and patients in intensive care unit require a central venous catheter (CVC) for infusion of medicaments and for monitoring. Central venous access (CVA) can be performed both with a blind technique or an ultrasound guided technique. A common place for CVA is the subclavian vein.

While many guidelines recommend the use of ultrasound for jugular access, there are no explicit recommendations for subclavian CVA For ultrasound guided CVA procedures good needle visualization is important to successfully place the needle and catheter in the correct position.

Echogenic needles can give better needle visualization when performing ultrasound guided CVA procedures. Theoretically, the use of echogenic needles should improve performance time and success rates, and reduce complication rates due to a better needling control.

The investigators will investigate the use of echogenic needles for vascular access.

A prospective randomized controlled trial design will be used. Echogenic needles will be compared with non-echogenic (standard) needles. The main null hypothesis states that there is no difference in access time between the needles.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

undergoing a surgical procedure requiring a CVC Patients must be at least 18 years of age. Patients that have given informed written consent.

Exclusion criteria

• Patients that do not speak or understand Norwegian language.
• Skin disease or infection affecting the whole-body surface or within the area of examination.
• Patients with untreated coagulopathy
• Known vascular abnormality
• Any reason why, in the opinion of the investigators, the patient should not participate.
• Subject participates in a potentially confounding drug or device trial during the course of the study.

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

100 participants in 2 patient groups

Echogenic needle

Active Comparator group

Description:

venous access performed under ultrasound guidance with echogenic needles

Treatment:

Device: echogenic needles for intravenous access

Non-Echogenic needles

No Intervention group

Description:

venous access performed under ultrasound guidance with non-echogenic needles